{"schema_version":"secwatch.filing_event.v1","accession":"0000051253-23-000015","form_type":"8-K","ticker":"IFF","cik":"0000051253","company_name":"INTERNATIONAL FLAVORS & FRAGRANCES INC","filed_at":"2023-05-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:41.887908+00:00","generated_at":"2026-06-15T14:39:05.073415+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"IFF reports Q1 2023: GAAP EPS $(0.04), adj. EPS $0.87; sales flat at $3.03B","bullets":["Reported net sales $3.03B flat YoY; currency-neutral comparable sales +1% led by Scent and Pharma.","GAAP EPS $(0.04); adjusted EPS ex amortization $0.87.","Adjusted operating EBITDA $503M, down 19% comparable currency-neutral; lower volumes and destocking offset pricing.","Cash from operations $127M; free cash flow -$48M; net debt to credit adjusted EBITDA 4.6x.","CEO says results in line/ahead of expectations but market conditions remain uncertain."],"urls":{"canonical":"https://secwatch.observer/filing/0000051253-23-000015","json":"https://secwatch.observer/filing/0000051253-23-000015.json","markdown":"https://secwatch.observer/filing/0000051253-23-000015.md","text":"https://secwatch.observer/filing/0000051253-23-000015.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/51253/000005125323000015/0000051253-23-000015-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/51253/000005125323000015/iff-20230508.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-15T14:39:05.073415+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"a7e948966b2fd9e5fee332d6acab5f1b007532cd","claim":"INTERNATIONAL FLAVORS & FRAGRANCES INC reported first quarter ended March 31, 2023 results: revenue $3.03 billion, EPS $(0.04).","evidence_excerpt":"drive portfolio optimization to generate strong returns for our shareholders.” First Quarter 2023 Consolidated Financial Results • Reported net sales for the first quarter were $3.03 billion, flat versus the prior-year period. On a comparable basis 2 , currency neutral sales increased 1% versus the prior-year period, led by Scent and Pharma Solutions. • Income before","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/51253/000005125323000015/0000051253-23-000015-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"first quarter ended March 31, 2023"},{"label":"Revenue","value":"$3.03 billion"},{"label":"EPS","value":"$(0.04)"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}